Manon Laporte
Papers
1
Total Citations
14
H-Index
1
About
Manon Laporte is a virologist whose work stands at the forefront of pandemic preparedness and antiviral drug discovery. Her primary research focuses on developing innovative, high-throughput screening (HTS) methodologies to identify therapeutic agents against emerging viral threats, most notably SARS-CoV-2. Her major contribution is the creation of a robust, dual-reporter HTS assay that enables the rapid, automated screening of thousands of compounds for antiviral activity. This fully automated system, detailed in her most-cited work (14 citations), bypasses the need for live virus handling in early-stage discovery, significantly accelerating the drug development pipeline. By providing a convenient and reliable platform, Laporte’s assay has become a critical tool for researchers worldwide seeking to repurpose existing drugs or discover new ones. Her work exemplifies the shift toward scalable, high-efficiency virology, directly impacting the global response to the COVID-19 pandemic and establishing a methodological blueprint for future outbreak responses.
Research Focus
Key Achievements
Top Papers
- 1